glp-1 agonist dementia GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation Advances in Clinical and Experimental

Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, Ohba K, Matsubara J, Maeda H, Horibata Y, Sakamoto K

But patients will need careful monitoring to make sure the weight they lose is mostly fat, not muscle

The combined activation might trigger metabolic changes that neither hormone produces alone

Now that GLP-1 agonists are a prominent treatment for overweight and obesity, researchers have begun looking at how patients with rheumatologic diseases respond to these products

Meta-analysis of these eight CVOTs with 60 080 patients included showed that GLP-1 receptor agonists reduce MACE and have a positive impact on chronic kidney disease in patients with T2D (30)

Druckers data were published a few months later, in May